Abstract Neuraminidase (NA) is one of the two glycoproteins on the surface of influenza virus, which cleaves terminal sialic acid residues and facilitates the release of virions from infected cells. The recombinant NA from H5N1 influenza virus strain A/Vietnam/1203/04 was expressed in Pichia pastoris X33 as a 45 kDa protein that displayed a K m of 9.96 ± 1.26 µM with fluorogenic substrate, 2'-(4-methylumbelliferyl)-α-D-N-acetyl neuraminic acid. Partially purified NA was used for the inhibition and kinetic assays with eight flavonoid compounds and gallic acid. Among them, gallocatechin gallate (GCG) showed the best inhibition against NA with the IC 50 of 8.98 ± 0.46 µM and showed a competitive inhibition pattern with K i value of 8.34 ± 0.25 µM. In molecular docking experiments, GCG displayed a binding energy of -13.71 kcal/mol to the active site of NA and the galloyl moiety was required for NA inhibition activity.
Introduction
Influenza A viruses caused annual outbreaks in humans and domestic animals. Three major influenza A pandemics were recorded during the 20 th century: the 1918-1919 "Spanish flu" representing the H1N1 influenza virus, the 1957-1958 "Asian flu" (H2N2), and the 1968-1969 "Hong Kong flu" (H3N2) [1] [2] [3] . The 1918-1919 pandemic caused the highest number of casualties: more than 500,000 people died in the USA, and more than 50 million people died worldwide [3] . The "Asian flu" in 1957-1958 caused about 70,000 deaths in the USA, and the "Hong Kong flu" in 1968-1969 caused about 34,000 deaths [1, 4] . Since 1997, different subtypes (H5N1, H7N7, and H9N2) of avian influenza viruses have been identified. Among them, the highly pathogenic H5N1 influenza viruses have severely affected to the poultry industry and posed a serious threat to human health, resulting in more than 50% fatality among more than 300 confirmed human cases [5] . The Influenza virus membranes contain two glycoproteins: haemagglutinin (HA) and neuraminidase (NA). HA mediates cell-surface sialic acid receptor binding to initiate virus infection. After virus replication, NA removes sialic acid from virus and cellular glycoproteins to facilitate virus release and the spread of infection to new cell. The distinct antigenic properties of different haemagglutinin and neuraminidase molecules are used to classify influenza type A viruses into subtypes: 16 for HA (H1-H16) and 9 for NA (N1-N9) [2] . Because of the importance of this enzyme in the pathogenesis of influenza virus infection, it has been regarded as a drug target for finding new drugs for the treatment of influenza [5, 6] . The avian H5N1 viruses might eventually become capable of species barrier crossing and of effective human to human transmission [1, 4] .
Flavonoids are a large group of naturally occurring phenolic compounds ubiquitously distributed in the plant kingdom. Over 4,000 varieties of flavonoids have been identified [7] . Flavonoids can act as potent antioxidants, display anti-inflammatory, antiallergic, antihemorrhagic, antimutagenic, antineoplastic, and hepatoprotective activities [7, 8] . There have some reports anti-influenza virus activities by inhibiting NA activity of several flavonoids compounds such as EGCG, EGC, and ECG against neuraminidase from A/H1N1, A/H3N2 and B virus [9] ; and 25 flavonoids (apigenin, catechin, epicatechin, luteolin, quercetin, rutin, etc) against neuraminidase from A/PR/8/34 (H1N1), A/ Jinan/15/90 (H3N2), and B/Jiangshu/10/2003 [10] . However, there has hitherto been no report on the strong inhibition activity of gallocatechin gallate (GCG) against NA from H5N1 influenza virus strain A/Vietnam/1203/04, or on the structure-activity relationship activity among the aforementioned flavonoid compounds against NA from H5N1. Herein, we report on the in vitro inhibition study using compounds belonging to four groups of flavonoids (flavonol, flavanonol, isoflavone, and flavan-3-ol) and gallic acid, against NA expression from Pichia pastoris X33 (P. pastoris X33) and the structure-activity relationship of them. The detailed mechanism of GCG inhibition was investigated by enzyme kinetic and molecular docking studies.
Material and Methods

Enzyme preparation
The procedures for construction, transformation, and screening for neuraminidase head domain (NA) of H5N1 influenza virus strain A/Vietnam/1203/04 were according to the manufacturer's instructions (Invitrogen, Carlsbad, USA). The vector pJ201 bearing gene encoding neuraminidase from H5N1 influenza virus strain A/Vietnam/1203/04 (amino acid residues: 63 -449, GenBank accession no. AY818141) was constructed and optimized genetic codons based of yeast P. pastoris using a custom gene synthesis service (DNA 2.0, Menlo Park, USA). The NA gene was isolated from the vector pJ201 by cutting with EcoRI and NotI and ligated into the EcoRI/NotI digested pPICZαA vector (pNA). This construct allows secretion of the neuraminidase into culture medium with in-frame Nterminal α-factor secretion signal and the C-terminal peptide containing the c-myc epitope and the polyhistidine tag. The resulting construct, pNA, was used to transform E. coli DH5α using a standard heat shock method. Transformants harbouring pNA were selected from LB agar low salt medium (1% w/v tryptone, 0.5% w/v yeast extract, 0.5% NaCl, pH 7.5) containing 25 µg/mL Zeocin TM . Plasmid pNA was amplified in E. coli DH5α and was linearized by SacI digestion and transformed into P. pastoris X-33 by modified lithium chloride methods [11] . Screening for positive clones was done by PCR method with two sets of primers: set one contained NA primers and set two contained α-factor and 3AOX1 primers. The PCR were conducted by using PCRmix (Bioneer, Daejeon, Korea) with thermal cycling of 95 To maintain methanol induction of the AOX1 promoter, 0.5% (v/v) methanol was fed every 24 h during the fermentation period. Protein expression of pPICZαA transformed into P. pastoris X-33 was conducted as negative control. The yeast cells were then separated from the broth by centrifugation at 8,000 × g for 15 min. The pellet was discarded and the supernatant was used for ammonium sulphate fractionation (0 ~ 90%). The fraction that showed enzyme activity was collected, dialyzed against 40 mM Na-P buffer (pH 7.0) and protein band was analyzed using SDS-PAGE and Western Blot.
Neuraminidase (NA) activity assay
Neuraminidase enzymatic activity assay measured 4-methylumbelliferone (4MU) released from the fluorogenic substrate 2'-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid (MUNANA, Sigma, St. Louis, USA). The reaction contained 0.34 units NA enzyme, 40 mM Na-P buffer (pH 7.0) and 20 µM MUNANA, the enzyme reaction was followed from 0 to 60 min at 37 o C using a fluorescence plate reader. The amount of fluorescent product, 4-methulumbeliferone was measure in a SpectraMax Gemini XPS (Molecular Devices, Sunnyvale, USA) with excitation and emission wavelengths of 355 and 460 nm, respectively. A standard curve was generated by plotting relative fluorescence intensity against the amount of free 4MU. One unit of NA was defined as one micro molar of 4MU produced per min at 37 o C. Kinetic parameters of recombinant neuraminidase were obtained using 5, 10, 15, 20, 40, and 60 µM MUNANA in the fluorescent assay at 52 min. Reactions were linear within this period. Michaelis-Menten constant (K m ) was calculated from the Lineweaver-Burk plot using the SigmaPlot program (SPSS, San Diego, USA).
2.3.
In vitro assay of NAH potential inhibitor activity Quercetin, puerarin, epigallocatechin (EGC), epigallocatechin gallate (EGCG), gallocatechin gallate (GCG), epicatechin gallate (ECG), and gallic acid were purchased from Sigma; ampelopsin was purchased from ZR chemicals (Shanghi, China). Ampelopsin glucoside was synthesized enzymatically and purified as described previously [12] . GCG, EGCG, EGC, ECG and ampelopsin glucoside were dissolved in water and quercetin, puerarin, gallic acid and ampelopsin were dissolved in DMSO at a stock concentration of 10 mM. Inhibitory activity of each test compound was determined by measurement of the remaining activity of NA at 200 µM of each tested compound. The enzymatic reaction was composed of 0.34 U/mL of enzyme, 10 µM MUNANA, 200 µM of test compound, and 40 mM potassium phosphate buffer (pH 7.0). Reactions were run for 30 min at 37 o C by continuous monitoring of fluorescence using a SpectraMax Gemini XPS apparatus with excitation and emission wavelengths of 355 and 460 nm, respectively.
The inhibition was calculated using the equation:
Where C is µM 4MU of the control (enzyme, buffer, and substrate) after 30 min of incubation, C 0 is µM 4MU of the control at zero time, S is µM 4MU of the tested samples (enzyme, sample solution, and substrate) after incubation, and S 0 is µM 4MU of the tested samples at zero time. The 50% inhibitory concentration (IC 50 ) was defined as the concentration of inhibitor necessary to reduce NA activity by 50% relative to a reaction mixture containing NA enzyme but no inhibitor.
Enzyme kinetics
Inhibition kinetic study was performed for GCG which was the best inhibitor against NA. The method was similar to those used in kinetic study of the recombinant enzyme, except for the use of multiple concentrations of the inhibitor (0 ~ 10 µM) and variable concentrations of substrate (5 1 0 µM). The type of inhibition was determined using Lineweaver-Burk plots and a Dixon plot (1/v as a function of inhibitor concentration, [I]) and kinetic parameters (K i ) was calculated using the SigmaPlot program.
Molecular docking study of neuraminidase with GCG
The Autodock 3.0.5 docking software [13] was used to perform the automated molecular docking between NA and GCG. The NA crystal structure [PDB code 2HU0 with inhibitor (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid (G39)] [2] was prepared for docking and post-docking refinement. For docking experiment between GCG and 2HU0, all water molecules and the inhibitor (G39) located in the active site of 2HU0 were removed, and the structure information containing only the amino acid residues of the NA enzyme was used. The process of molecular docking used between GCG and NA has been described previously [14, 15] . The hydrogen interaction between GCG and NA active site pocket was visualize by Ligplot software [16] .
Results and Discussion
Preparation of recombinant NA
We prepared active NA of H5N1 (CAZy -Glycoside hydrolase family 34) which is different from commercially available NA from Clostridium perfringens (CAZyGlycoside Hydrolase family 33). The 1161 bp gene encoding for 387 amino acids residues (63 ~ 449) of NA from Influenza virus A/Vietnam/1203/2004 H5N1 was cloned into the pPICZáA expression vector (pNA) and the pNA plasmid was linearized by SacI digestion that was further incorporated into the AOX1 locus of P. pastoris. A single clone was selected for expression; the recombinant NA was resolved electrophoretically as a band of approximately 45 kDa (Fig. 1A) . To confirm that the clone secreted NA, Western blotting (Fig. 1B) was performed using the anti-His antibody; NA was apparent as the same band upon SDS-PAGE. To calculate the kinetic parameters of NA, enzyme activity was analyzed with fluorescent substrate ranging from 5 to 60 µM (final concentration). The Linewaever-Burk plot showed linear line interception on the 1/v axis. The Michaelis-Menten constant K m derived from the Lineweaver-Burk plot was 9.96 ± 0.26 µM (Fig. S1 ).
NA inhibition by flavonoid compounds
The inhibitory activity of gallic acid and eight flavonoid compounds belonging to four groups of flavonoids (flavanonol (ampelopsin, ampelopsin glucoside), flavonol (quercetin), isoflavones (puerarin), and flavan-3-ol (EGC, ECG, EGCG, GCG)) against NA were examined at a concentration of 200 µM. The primarily inhibition activity results were showed in Table 1 . EGC and gallic acid inhibited 9.3 and 14.0% of NA activity. Ampelopsin inhibited 27.9% of NA activity while ampelopsin glucoside inhibited 58.2% of NA activity. Quercetin inhibited 35.2% of NA activity. ECG inhibited 36.7% of NA activity, EGCG inhibited 58.0%, and GCG inhibited 87.1% of NA activity. Among the tested compounds, GCG, the best inhibitor against NA with an IC 50 value of 8.98 ± 0.46 µM, was used to analyze the mode of inhibition. For the analysis of the inhibition mode of GCG, both LineweaverBurk and Dixon plots were used. K i value was calculated from the Dixon plots using the SigmaPlot program. The inhibition of NA by GCG is illustrated in Fig. 2 . GCG exhibited competitive inhibition toward NA because the Lineweaver-Burk plot of 1/v versus 1/[S] resulted in a family of straight lines with the same y-axis intercept ( Fig. 2A) . The K i value of GCG was determined to be 8.34 ± 0.25 µM, from the common x-axis intercept of lines on the corresponding Dixon plot (Fig. 2B ).
Molecular docking between NA and GCG
To further investigate the interaction of GCG with the NA enzyme, molecular docking simulations of the binding of GCG at the NA active site (X-ray crystal structure with PDB code 2HU0) was carried out using Autodock 3.0.5. The free binding energy of GCG was determined to be -13.71 kcal/mol. The binding between GCG and the active site pocket of NA is shown in Fig. 3A . To elucidate the interaction of NA with GCG, the potential hydrophobic and H-bonds interactions between amino acid residues at the active site of NA and GCG were investigated using the Ligplot program. 3.4. Structural activity relationship of flavonoids compounds against NA EGC, ECG, ampelopsin, EGCG and GCG contain the same B-ring and the increasing order inhibitory activity was EGC < ampelopsin < EGCG < GCG. EGCG and GCG have a galloy moiety at the 3-OH position, displayed stronger NA inhibitory activity than EGC and ampelopsin. So gallic acid was used for in vitro assay, and it showed 14.0% inhibition activity against NA from H5N1 at 200 µM. These results were similar with previous report about potent inhibitors of influenza virus growth including A/H1N1, A/H3N2 and B virus in MDCK cells of EGCG, ECG, EGC and the results showed that galloy group at the 3-OH of catechin skeleton plays an important role on the observed antiviral activity [9] . However, comparison between EGCG and GCG, GCG (2S, 3R type), which is a C-2 epimeric isomer of EGCG (2R, 3R type) showed 1.5-times higher NA inhibitory activity than EGCG. Puerarin which lack the B-ring, showed higher inhibitory activity compared with ampelopsin and quercetin. Quercetin which lacks the 5'-OH group of B ring and contains 2, 3-double bonds showed a bit higher inhibitory activity compare with ampelopsin but ampelopsin glucoside showed higher inhibitory activity, 1.7 and 2.1-times, than quercetin and ampelopsin, respectively. The attached glucose at 4'-OH of B-ring enhanced NA inhibitory activity. EGC lacking the C(4)=O in the C-ring and galloy moiety group showed lowest inhibitory activity compared to that ampelopsin, quercetin, puerarin. C(4)=O in the C-ring is important to enhance inhibitory activity.
Conclusion
For the first time, the active extracellular NA of H5N1 influenza virus strain A/Vietnam/1203/04 was successfully expressed in P. pastoris X33. Among the investigated flavonoids, GCG was shown as the best comparative inhibitor against NA by in vitro assay. The structure and inhibition activity relationship among eight flavonoid compounds was also investigated. GCG showed numerous hydrophobic and H-bonds interaction with amino acid residues in active site pocket of NA.
